Rheumatoid Arthritis News
- Bad news for avid smokers Fri, 21 Nov 2008 02:15:37 -0600For those of you still thinking about smoking cessation or even considering starting smoking, here’s something to ponder: If you thought tobacco was only associated with lung cancer and heart disease, we have some bad news for you.
- Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline Thu, 20 Nov 2008 21:52:50 -0600Novartis highlighted at an investor event on November 19, the success of its pharmaceuticals research strategy in delivering novel compounds to the clinic, reflecting the benefits of sustained investments in Research and Development.
- Ruling upheld on disabled travel Fri, 21 Nov 2008 03:46:46 -0600Calgary law professor Linda McKay-Panos won a legal battle yesterday that will allow her and thousands of other Canadians to fly in greater comfort and dignity.
- Air Canada Can't Make Disabled People Pay Extra Seat (Update4) Thu, 20 Nov 2008 18:36:56 -0600Nov. 20 (Bloomberg) -- Air Canada , the country's biggest airline, and other carriers can't charge disabled or obese people for an extra ticket when they need an additional seat or an attendant to accompany them.
- Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union Fri, 21 Nov 2008 08:44:11 -0600Thousand Oaks, California, November 21 (ots/PRNewswire) - - First and Only Approved Platelet Producer Represents New Treatment Approach for Serious Chronic Autoimmune Disorder Amgen (Nasdaq: AMGN) today announced that the ...
- Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union Fri, 21 Nov 2008 08:39:19 -0600Thousand Oaks, California, November 21 (ots/PRNewswire) - - First and Only Approved Platelet Producer Represents New Treatment Approach for Serious Chronic ...
- Top court won't hear airlines' two-seats-for-obese-passenger appeal Thu, 20 Nov 2008 15:58:09 -0600Canada's two largest airlines must give disabled and morbidly obese passengers an extra free seat on domestic flights, beginning in January, after the Supreme Court of Canada refused Thursday to consider the carriers' appeal to a federal order.
- Court ruling means airlines must make room for disabled Thu, 20 Nov 2008 16:27:35 -0600OTTAWA (CP) — Three of the country’s major airlines are finally being forced — after a six-year-legal battle — to make additional seats available at no charge to disabled or obese passengers who need the extra room.
- COMING UP Thu, 20 Nov 2008 05:30:10 -0600PAN-AMERICAN EXPO: Librarian Raya Lee will discuss the Pan- American Expositionat a meeting of the Cheektowaga Historical Association at 7 p. m. today in Alexander Community Center, 275 Alexander St., Cheektowaga.
- Top court to rule on appeal bid from airlines over free seats for disabled Thu, 20 Nov 2008 05:28:27 -0600Canada's top court will rule Thursday whether it will hear an appeal from Canadian airlines, which say they shouldn't have to provide a free extra seat to certain disabled and obese people.
- Top court backs free seat ruling for some disabled, obese travellers Thu, 20 Nov 2008 06:13:18 -0600The Supreme Court on Thursday backed a Canadian Transportation Agency ruling ordering Canadian airlines to offer a free seat to certain disabled and obese people.
- Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union Fri, 21 Nov 2008 08:25:00 -0600 Amgen today announced that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorisation for Nplate in the European Union .
- Coping with Lyme disease Fri, 21 Nov 2008 06:49:18 -0600Three generations of a Jack Tobichuk's Foxboro family have been stricken with Lyme disease. And Foxboro police officer Doug Miller is quietly suffering with late-stage Lyme.
- Health Robotics Announces $60M Investment by Devon International Group and ITOCHU Inc. in the CytoCare(TM) and ... Fri, 21 Nov 2008 08:00:00 -0600 Health Robotics today announced that it has signed a definitive agreement with Devon International Group and its strategic partner ITOCHU International, Inc., whereby DIG and ITOCHU have acquired the exclusive rights to manufacture, market, sub-license, implement, interface, and support Health Robotics' robots in the United States, Canada, Mexico, and the Caribbean Islands.
- One airfare for disabled, obese Fri, 21 Nov 2008 02:57:24 -0600Canada's largest airlines must give disabled and morbidly obese passengers an extra free seat on domestic flights, beginning in January, after the Supreme Court of Canada refused Thursday to consider the carriers' appeal to a federal order.
- Amgen, Takeda And Millennium Provide Update On Phase 3 Trial Of Motesanib In Patients With Non Small Cell Lung Cancer Fri, 21 Nov 2008 05:18:44 -0600Amgen (Nasdaq: AMGN) and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4052), announced that enrollment in the Phase 3 MONET1 trial evaluating motesanib (AMG 706) in combination with paclitaxel and carboplatin for the first-line treatment of adva
- Musculoskeletal Center Wins $2.2 Million for Drug Safety Tue, 18 Nov 2008 13:28:36 -0600The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called 'biologics' -- genetically engineered agents targeting the immune system of patients with rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders. The grant will allow the UAB center to pinpoint which biologics have ...
- What Gene Tests Can Really Tell You Thu, 20 Nov 2008 07:08:43 -0600 If Greg Lennon is right, then the personal genome gold rush has a major flaw: There's not much gold there -- not yet.
- Musculoskeletal center wins $2.2 million for drug safety Tue, 18 Nov 2008 12:18:34 -0600( University of Alabama at Birmingham ) The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called "biologics." These are agents genetically engineered to target the immune system of patients with rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders. The grant will allow the ...
- Musculoskeletal Center wins $2.2 million to study biologics safety Tue, 18 Nov 2008 21:56:57 -0600The UAB Center for Education and Research on Therapeutics has won a $2.2 million federal grant to study the risks and benefits of a class of drugs called ‘biologics' -- genetically engineered agents targeting the immune system of patients with rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.
- Howard got the big prize this season Sat, 22 Nov 2008 23:17:21 -0600I was hoping to write about some of the free-agent signings in baseball, but since not much is happening yet on that front here are a few musings on some other topics.• I'm not the least bit upset that the Phillies' Ryan Howard finished second in the MVP voting to the Cardinals' Alb...
- Painful jaws Sat, 22 Nov 2008 18:26:40 -0600Temporo-mandibular disorders (those that affect the joint that joins the upper and lower jaw) are quite common.
- National program putting cure for arthritis Within Our Reach Sat, 15 Nov 2008 23:22:39 -0600When Kristin Fisher suffered from rheumatoid arthritis, just climbing the stairs and cleaning the house were beyond painful for her. "I don't know what brought...
- CHMP Recommends Approval Of New Indication For Enbrel(R) As Treatment For Severe Psoriasis In Paediatric Patients Sat, 22 Nov 2008 05:15:34 -0600The European Committee for Medicinal Products for Human Use (CHMP) announced its positive recommendation for the approval of Enbrel(R) (etanercept) as a treatment for children aged 8 years and over and adolescents with severe plaque psoriasis.
- My Pharmiweb.com Tue, 18 Nov 2008 09:04:08 -0600• RAPID 2 trial showed CIMZIA®, together with methotrexate (MTX), achieved significant reduction in signs, symptoms and progression of rheumatoid arthritis Brussels, Belgium, November 18 2008 — UCB today announced the results of two phase III studies, published in the Annals of the Rheumatic Diseases Online this week, showing CIMZIA® (certolizumab pegol), the only PEGylated anti-TNF?
- From vitamin C to fish oil, we sample the supplements Fri, 21 Nov 2008 19:14:57 -0600Do supplements boost our health or are they a waste of money? To supplement or not to supplement - that is the question facing health-conscious consumers.
- Advertising pioneer George Beach to be honored Fri, 21 Nov 2008 02:47:29 -0600The interview was winding down, and longtime advertising executive George Beach had begun to relax a little. So, laughing, he showed off the cool trick he can do with his arm.
- Building Immunity Naturally, Part 2 Fri, 21 Nov 2008 21:15:34 -0600Practice the basics of good health. Drink plenty of water. Many people get dehydrated in the winter and this puts your body at risk. Eat a good balance diet with lean protein, good quality fats (such as omega 3 fish oil), lots of fresh fruits and vegetables.
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients Fri, 21 Nov 2008 07:52:27 -0600Maidenhead, England, November 21 (ots/PRNewswire) - - Not for UK Journalists The European Committee for Medicinal Products for Human Use (CHMP) today ...
- (AFX UK Focus) 2008-11-21 13:38 BRIEF-Roche-RoActemra gets positive opinion in Europe Fri, 21 Nov 2008 08:09:14 -0600ZURICH, Nov 21 (Reuters) - Roche Holding AG:
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients Fri, 21 Nov 2008 07:43:49 -0600Maidenhead, England, November 21 (ots/PRNewswire) - - Not for UK Journalists The European Committee for Medicinal Products for Human Use (CHMP) today announced its positive recommendation for the approval of Enbrel(R) ...
- ZymoGenetics' longtime CEO is stepping down Fri, 21 Nov 2008 11:14:24 -0600ZymoGenetics CEO Bruce Carter will step down in January, and will be replaced by Douglas Williams.
- Disabled, obese to get extra seat - Airlines lose battle, must make room Fri, 21 Nov 2008 12:15:20 -0600Three of the country's major airlines are finally being forced -- after a six-year-legal battle -- to make additional seats available at no charge to [...]
- Disabled, obese get free seats on airlines Fri, 21 Nov 2008 04:31:07 -0600 OTTAWA -- Canada's two largest airlines must give disabled and morbidly obese passengers an extra free seat on domestic flights, beginning in January, after the Supreme Court of Canada refused yesterday to consider the carriers' appeal of a federal order.
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients Fri, 21 Nov 2008 07:30:00 -0600 -
- Advertising pioneer George Beach to be honored Thu, 20 Nov 2008 16:52:55 -0600The interview was winding down, and longtime advertising executive George Beach had begun to relax a little.
- Gift of laughter saw June Suttie of Zellwood through illness, loss Sat, 22 Nov 2008 07:12:57 -0600No matter how difficult life got, June Suttie of Zellwood kept on laughing.
- One woman's island Sun, 23 Nov 2008 03:31:46 -0600Life's a laugh... Jean Wilton. Photo: Chris Sant Fournier Since her first visit in 1946, Jean Wilton, 80, has seen war-ravaged Malta slowly being built up. Over 100 visits later, she speaks to Veronica Stivala.
- Melatonin may save eyesight in inflammatory disease Sat, 22 Nov 2008 23:20:36 -0600( American Journal of Pathology ) Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease.
- Musculoskeletal Center Wins $2.2 Million For Drug Safety Wed, 19 Nov 2008 11:18:14 -0600The University of Alabama at Birmingham (UAB) Center for Education and Research on Therapeutics (CERTs) has won a $2.2 million federal grant to study the risks and benefits of a newer class of medicines called biologics. These are genetically engineered therapies that target the immune system of patients who have rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders.
- Change to GP dispensing opposed Sat, 22 Nov 2008 19:50:49 -0600Patients oppose plans to reduce the ability of rural GPs in England to provide drugs directly to their patients, a poll suggests.
- Returned to senders Fri, 21 Nov 2008 11:03:54 -0600As a side effect of her rheumatoid arthritis, Charlotte Santos, 63, seldom drives, does not walk great distances and relies on a cane to get around her residence at Jackson Manor Apartments.
- RoActemra Receives Positive Opinion In Europe For The Treatment Of Rheumatoid Arthritis Sat, 22 Nov 2008 05:18:44 -0600Roche announced that the European Committee on Human Medicinal Products (CHMP) has given a positive recommendation for RoActemra (tocilizumab, known as Actemra outside of the EU), in combination with methotrexate (MTX), for the treatment of adult patients with moderate to severe rheumatoid arthritis
- Vitamin E won't prevent rheumatoid arthritis: study Thu, 20 Nov 2008 11:43:19 -0600 Taking vitamin E supplements does not reduce a woman's risk of rheumatoid arthritis (RA), an analysis of data from the Women's Health Study indicates.
- MedPredict's Rheumatology Panel Analyzes Rheumatoid Arthritis, Lupus and Gout Markets and Pipelines Following ACR ... Thu, 20 Nov 2008 10:39:00 -0600 MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for Rheumatoid Arthritis , lupus and gout therapies.
- Two Scandinavian Studies Link Moderate Drinking to Sharply Reduced Arthritis Risk Fri, 21 Nov 2008 14:28:02 -0600"The major finding of this study is that alcohol consumption exhibits a dose-dependent inverse association with rheumatoid arthritis." So concluded the authors of a pair of Scandinavian studies.
- Rheumatoid Arthritis - Cimzia(R) Studies Show Significant Clinical Benefits For Mono- And Combination Therapy Tue, 18 Nov 2008 08:15:54 -0600UCB today announced the results of two phase III studies, published in the Annals of the Rheumatic Diseases Online, showing Cimzia® (certolizumab pegol), the only PEGylated anti-TNFalpha (Tumour Necrosis Factor alpha), provided significant clinical benefits as monotherapy, and in combination with methotrexate, in adults with active rheumatoid arthritis (RA).
- UCB reports positive results from two Phase III arthritis trials Thu, 20 Nov 2008 05:27:31 -0600UCB, a biopharmaceutical and specialty chemical company, has announced the results of two Phase III studies, showing Cimzia, the only PEGylated anti-TNFalpha, provided significant clinical benefits as monotherapy, and in combination with methotrexate, in adults with active rheumatoid arthritis.
- Healthwatch: Treatment for Arthritis Thu, 20 Nov 2008 11:51:32 -0600A growing number of young people are being diagnosed with arthritis. But help is available for the young, as well as older patients.
- Ayurvedic remedy for arthritis? Fri, 21 Nov 2008 14:36:42 -0600Arthritis is generally known as an old age affliction. Most of us have either seen somebody in the family suffering from arthritis or known someone who has it. Arthritis is a chronic disease and can be very painful.
